Last reviewed · How we verify

NCT05669508: RISES-T

Wearable Electrical Stimulation on the Back to Modulate Spinal Cord Activity

Active, enrolled NA Last updated 11 April 2025
What this trial tests

NA trial testing RISES-T System in Spinal Cord Injuries in 4 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
10 February 2022
Primary endpoint
31 December 2025
31 December 2026

Quick facts

Lead sponsorThomas Jefferson University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment4
Start date10 February 2022
Primary completion31 December 2025
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Thomas Jefferson University

Who can join

Adults 18 to 55, any sex, with Spinal Cord Injuries or Spinal Cord Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to evaluate if non-invasive electrical spinal stimulation can help people with paralysis caused by SCI improve strength and function of their arms, legs, hands or feet. The study will involve therapy sessions involving exercises done at the same time as electrical stimulation therapy. This study has multiple parts to evaluate the effectiveness and safety of "smart" electrical stimulation of the spinal cord, which involves stimulating the spinal cord at precise locations and times to improve movement and function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of RISES-T System

Trials testing the same drug.

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other Thomas Jefferson University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05669508.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing